Third Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. Topics Covered: 00:00 Introduction 01:00 COVID-19 update and news 05:08 Can scientists/physicians make a difference in debunking...
Topics Covered: 00:00 – Introduction 00:55 – Global COVID-19 situation: cases continue to decline 05:26 – AZD7442 – mAB for prevention of COVID-19 09:12 – Lack of Immune response to SARS-CoV2 in...
Download the PDF here. Click here for more Global Health Casts: 🔒 Premium Content - For FreeUnlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable...
Three new observational studies from Scotland, Denmark, and the United States detail reduced hospitalizations and emergency department (ED) visits for Omicron COVID-19 infections relative to those caused by the Delta...
The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and...
The human body’s T cells provide long-lasting memory against the virus following vaccination or infection from COVID-19, a study led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) has...
Kenya identified its first case of Covid-19 on 12th March 2020. It has since then undertaken a series of measures to contain the spread and management of the disease in the country. In a population of approximately 54...
High coverage rates of vaccination against COVID-19 are envisaged to end the pandemic. However, waning of vaccine-induced protection is a growing concern that has been fostered by data on vaccine effectiveness against...
The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of COVID-19 have not yet been comprehensively characterized. Here we...
New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that, although over time the number of SARS-CoV-2 antibodies...